ABSTRACT
Human Immunodeficiency Virus (HIV) is the etiological agent for Acquired Immunodeficiency Syndrome (AIDS). It is possible that vaccine failure could be related to the events involved at the origin of HIV/AIDS. In this work the role of the adjuvant activation hypothesis on the origin and on the failure of vaccines, as well as other effects is evaluated by means of a simulation using a mathematical analysis, differential equations and an Excel spreadsheet. The results show that the adjuvant activation alters the viral load and the cellular and humoral Immune Response. Under certain conditions it was possible to show how the adjuvant activation could have promoted the origin of the HIV/AIDS pandemic and also, as a consequence of the SIV adaptation to human beings at the origin, the failure of present day vaccine trials. Other effects such as Immunotolerance and Antibody Dependent Enhancement (ADE) were shown. This study provides a means to examine other effectors in order to suggest therapeutic alternatives. In this case passive immunization in combination with anti-retroviral therapy showed an acceptable adaptation to the conditions tested. It is concluded that the methodological strategy of this work may be useful for the analysis of the adjuvant activation hypothesis as well as other effects, interactions and new proposals, such as thermodynamics of HIV infections.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work received no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work was not performed with patients or their real data
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available
